COVID-19 morbidity decreases with tixagevimab-cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders

Affiliations

• ¹ Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France.
• ² Department of Pharmacy, Bordeaux University Hospital, Bordeaux, France.
• ³ Department of Nephrology, Centre Hospitalier de Saintes, Saintes, France.
• ⁴ Department of Nephrology, Centre Hospitalier de Pau, Pau, France.
• ⁵ Clinique Saint-Augustin Centre de Traitement des Maladies Rénales (CTMR), Bordeaux, France.
• ⁶ Department of Nephrology, Centre Hospitalier de Mont de Marsan, Mont de Marsan, France.
• ⁷ Department of Nephrology, Centre Hospitalier de Bayonne, Bayonne, France.
• ⁸ Department of Virology, Bordeaux University Hospital, Bordeaux, France.
• ⁹ Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France. Electronic address: lionel.couzi@chu-bordeaux.fr.